CHEBI:233446 - suzetrigine

ChEBI IDCHEBI:233446
ChEBI Namesuzetrigine
Stars
DefinitionA member of the class of oxolanes that is oxolane substituted by 4-aminoacyl-pyridine-2-carboxamide, 3,4-difluoro-2-methoxyphenyl, methyl, and trifluoromethyl groups at positions 2, 3, 4, 5, and 5, respectively (the 2R,3S,4S,5R-stereoisomer). It is a selective blocker of the NaV 1.8 voltage-gated sodium channel and has been approved for the treatment of moderate to severe acute pain in adults.
Last Modified5 February 2025
SubmitterAdnan
DownloadsMolfile
FormulaC21H20F5N3O4
Net Charge0
Average Mass473.398
Monoisotopic Mass473.13740
SMILESCOc1c([C@H]2[C@H](C(=O)Nc3ccnc(C(N)=O)c3)O[C@@](C)(C(F)(F)F)[C@H]2C)ccc(F)c1F
InChIInChI=1S/C21H20F5N3O4/c1-9-14(11-4-5-12(22)15(23)16(11)32-3)17(33-20(9,2)21(24,25)26)19(31)29-10-6-7-28-13(8-10)18(27)30/h4-9,14,17H,1-3H3,(H2,27,30)(H,28,29,31)/t9-,14-,17+,20+/m0/s1
InChIKeyXSQUJFKRXZMOKA-PAFIKIDNSA-N
Wikipedia
Roles Classification
Biological Roles:
non-narcotic analgesic  A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
voltage-gated sodium channel blocker  Any sodium channel blocker that interferes with the activity of voltage-gated sodium channels.
Application:
non-narcotic analgesic  A drug that has principally analgesic, antipyretic and anti-inflammatory actions. Non-narcotic analgesics do not bind to opioid receptors.
ChEBI Ontology
Outgoing Relation(s)
suzetrigine (CHEBI:233446) has role non-narcotic analgesic (CHEBI:35481)
suzetrigine (CHEBI:233446) has role voltage-gated sodium channel blocker (CHEBI:38634)
suzetrigine (CHEBI:233446) is a difluorobenzene (CHEBI:38582)
suzetrigine (CHEBI:233446) is a monomethoxybenzene (CHEBI:25235)
suzetrigine (CHEBI:233446) is a oxolanes (CHEBI:26912)
suzetrigine (CHEBI:233446) is a primary carboxamide (CHEBI:140324)
suzetrigine (CHEBI:233446) is a pyridinecarboxamide (CHEBI:25529)
suzetrigine (CHEBI:233446) is a secondary carboxamide (CHEBI:140325)
IUPAC Name 
4-({[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)tetrahydrofuran-2-yl]carbonyl}amino)pyridine-2-carboxamide
INNs  Source
suzétrigineWHO MedNet
suzetrigineWHO MedNet
suzetriginaWHO MedNet
suzetriginumWHO MedNet
Synonyms  Source
VX-548DrugBank
VX548DrugBank
VX 548DrugBank
4-[(2R,3S,4S,5R)-3-(3,4-difluoro-2-methoxyphenyl)-4,5-dimethyl-5-(trifluoromethyl)oxolane-2-amido]pyridine-2-carboxamideChEBI
Brand Name  Source
JOURNAVXChEBI
Manual XrefsDatabases
DB18927DrugBank
D12860KEGG DRUG
SuzetrigineWikipedia
WO2021113627Patent
Registry NumbersSources
CAS:2649467-58-1KEGG DRUG
Citations